Dr. Lal Pathlabs Q3 Results
- BSE: 539524
- NSE: LALPATHLAB
- ISIN: INE600L01024
- Sector: Healthcare Facilities
BSE
2,766.5
-41.10 (-1.46%)
-41.10 (-1.46%)Volume4.63 K
Updated: Wed 15 Jan, 2025 | 15:24:10
NSE
2,774.55-28.50 (-1.02%)
-28.50 (-1.02%)Volume2.06 L
Updated: Wed 15 Jan, 2025 | 15:10:52
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Dr. Lal Pathlabs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 538.90 | 601.30 | -10.38% | 538.90 | N/A |
| Selling/ General/ Admin Expenses Total | 186.70 | 190.60 | -2.05% | 186.70 | N/A |
| Depreciation/ Amortization | 36.00 | 35.90 | 0.28% | 36.00 | N/A |
| Other Operating Expenses Total | 104.60 | 110.50 | -5.34% | 104.60 | N/A |
| Total Operating Expense | 434.30 | 459.40 | -5.46% | 434.30 | N/A |
| Operating Income | 104.60 | 141.90 | -26.29% | 104.60 | N/A |
| Net Income Before Taxes | 115.90 | 152.20 | -23.85% | 115.90 | N/A |
| Net Income | 81.30 | 109.30 | -25.62% | 81.30 | N/A |
| Diluted Normalized EPS | 9.76 | 13.12 | -25.61% | 9.76 | N/A |